{"id":"W2010208199","doi":"10.1158/0008-5472.sabcs13-p4-12-16","title":"Abstract P4-12-16: Safety profile and costs of related adverse events of trastuzumab emtansine compared to other regimens in the Canadian health care system","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Trastuzumab emtansine; Medicine; Trastuzumab; Taxane; Lapatinib; Internal medicine; Capecitabine; Docetaxel; Adverse effect; Oncology; Breast cancer; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001325437,0.0002589345,0.0004929761,0.001086188,0.0008094007,0.001066221,0.0009120048,0.0003931277,0.005603603],"category_scores_gemma":[0.008874555,0.0001427578,0.001001481,0.002251077,0.0003002406,0.0003575304,0.0005786882,0.0006975905,0.0001864911],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.02914511,"about_ca_system_score_gemma":0.02383505,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.734333,"about_ca_topic_score_gemma":0.7924813,"domain_scores_codex":[0.9979454,0.0004338569,0.0001531662,0.0001957418,0.001031143,0.0002406967],"domain_scores_gemma":[0.9943544,0.0006700322,0.001859186,0.0001373249,0.001947994,0.001031005],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02059179,0.001022524,0.5376472,0.001828108,0.001969541,0.0004032999,0.0003345576,0.005474953,0.001694873,0.00158588,0.03343994,0.3940074],"study_design_scores_gemma":[0.001728626,0.003258386,0.9730334,0.0004286339,0.0006171804,0.000291258,0.0002693352,0.004357692,0.0007276512,0.000230893,0.01501112,0.00004577683],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9374922,0.02167711,0.0004821846,0.004706013,0.0001004387,0.000598731,0.01676212,0.00007994573,0.01810115],"genre_scores_gemma":[0.9896508,0.003638936,0.0004484805,0.0005440536,0.0000569235,0.00009070674,0.003565997,0.00001053652,0.001993458],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.265667,"threshold_uncertainty_score":0.534463,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08097982633674465,"score_gpt":0.4264905827496397,"score_spread":0.3455107564128951,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}